Rigel Pharmaceuticals Inc
RIGL
Revenue
69.80M
▲340.00k▲0.4895%
3 Months ChangeAssets
513.59M
▲271.06M▲111.76%
3 Months ChangeLiabilities
122.11M
▼-2.81M▼-2.25%
3 Months ChangeFree Cash Flow
-25.86M
▼-5.84M▼-29.14%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001034842-26-000016
2026-02-03
Form 8-K
ID: 0001034842-26-000007
2026-01-12
Form 8-K
ID: 0001034842-26-000005
2025-12-10
Form 8-K
ID: 0001104659-25-119976
2025-11-04
Form 8-K
ID: 0001104659-25-106282
2025-11-04
Form 10-Q
ID: 0001104659-25-106268
2025-08-05
Form 10-Q
ID: 0001558370-25-010281
2025-08-05
Form 8-K
ID: 0001104659-25-074163
2025-05-23
Form 8-K
ID: 0001104659-25-052407
2025-05-06
Form 8-K
ID: 0001104659-25-045067